BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30197623)

  • 1. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.
    Nagarajan A; Malvi P; Wajapeyee N
    Front Endocrinol (Lausanne); 2018; 9():483. PubMed ID: 30197623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycans in cancer: Pathogenesis and therapeutic potential.
    Yang H; Wang L
    Adv Cancer Res; 2023; 157():251-291. PubMed ID: 36725112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion.
    Marques C; Poças J; Gomes C; Faria-Ramos I; Reis CA; Vivès RR; Magalhães A
    J Biol Chem; 2022 Nov; 298(11):102546. PubMed ID: 36181793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.
    Billings PC; Pacifici M
    Connect Tissue Res; 2015; 56(4):272-80. PubMed ID: 26076122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.
    O'Callaghan P; Zhang X; Li JP
    J Histochem Cytochem; 2018 Apr; 66(4):305-319. PubMed ID: 29290138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan Sulfate in the Tumor Microenvironment.
    Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
    Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
    De Pasquale V; Pavone LM
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression.
    Marques C; Reis CA; Vivès RR; Magalhães A
    Front Oncol; 2021; 11():778752. PubMed ID: 34858858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate proteoglycans as multifunctional cell regulators: cell surface receptors.
    Li JP; Spillmann D
    Methods Mol Biol; 2012; 836():239-55. PubMed ID: 22252639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate proteoglycans in glomerular inflammation.
    Rops AL; van der Vlag J; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; Berden JH
    Kidney Int; 2004 Mar; 65(3):768-85. PubMed ID: 14871397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coreceptor functions of cell surface heparan sulfate proteoglycans.
    Hayashida K; Aquino RS; Park PW
    Am J Physiol Cell Physiol; 2022 May; 322(5):C896-C912. PubMed ID: 35319900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
    Lanzi C; Zaffaroni N; Cassinelli G
    Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.
    Fernández-Vega I; García-Suárez O; García B; Crespo A; Astudillo A; Quirós LM
    BMC Cancer; 2015 Oct; 15():742. PubMed ID: 26482785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.
    Hammond E; Khurana A; Shridhar V; Dredge K
    Front Oncol; 2014; 4():195. PubMed ID: 25105093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.
    De Pasquale V; Quiccione MS; Tafuri S; Avallone L; Pavone LM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans.
    van der Voort R; Keehnen RM; Beuling EA; Spaargaren M; Pals ST
    J Exp Med; 2000 Oct; 192(8):1115-24. PubMed ID: 11034601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells.
    Papy-Garcia D; Albanese P
    Glycoconj J; 2017 Jun; 34(3):377-391. PubMed ID: 28577070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.